The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency
Matthias R. Baumgartner(University of Zurich), David Valle(Johns Hopkins University), Seymour Packman(University of California, San Francisco), Cassandra Obie(Howard Hughes Medical Institute), Terttu Suormala(Johns Hopkins University), Shlomo Almashanu(Howard Hughes Medical Institute), E. R. Baumgartner(University Children’s Hospital Basel), Robert N. Cole(Johns Hopkins University)
Cited by 118
Related Papers
Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper–transporting ATPase
|Nature Genetics|1993|1.4k
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia
|Orphanet Journal of Rare Diseases|2014|713
Agalsidase-Beta Therapy for Advanced Fabry Disease
|Annals of Internal Medicine|2007|565
Sir2-Dependent Activation of Acetyl-CoA Synthetase by Deacetylation of Active Lysine
|Science|2002|563
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555